Pathology: Page 38

Licofelone inhibits oral cancer growth in rat study
By DrBicuspid.com staff writers
The compound licofelone inhibited oral cancer growth by inhibiting the cyclooxygenase (COX) and 5-lipoxygenase pathways, according to a study presented at this week's American Association for Cancer Research International Conference in Anaheim, CA.
October 18, 2012
Survey: Many with diabetes unaware of oral health connection
By DrBicuspid.com staff writers
A survey conducted on behalf of Colgate Total revealed a lack of awareness about the various health issues associated with diabetes.
October 16, 2012
New 'rinse and spit' oral cancer test shows promise
By DrBicuspid.com staff writers
A "rinse and spit" test for early detection of oral cancer performed well in a clinical feasibility study, according to Vigilant Biosciences, the company commercializing the product.
October 16, 2012
NIH grant to fund new oral cancer treatment
By DrBicuspid.com staff writers
The University of Rochester Medical Center and Lucifics, a photomedical technology start-up company, have been awarded a grant from the National Institutes of Health (NIH) to develop and test prototypes of a new generation of medical devices to treat oral cancer.
October 15, 2012
NUS engineers improve throat cancer treatment
By DrBicuspid.com staff writers
Patients who lose their ability to speak after surgical treatment for throat cancer may be able to regain that ability much more quickly thanks to a new device developed by researchers at the National University of Singapore (NUS).
October 11, 2012
Environment a bigger factor than genes in oral bacteria
By DrBicuspid.com staff writers
The makeup of bacteria in the oral cavity is driven more by environmental factors than genetics, according to a new long-term study of human twins by University of Colorado Boulder researchers.
October 11, 2012
Age 45 still best marker to predict thyroid cancer outcomes?
By DrBicuspid.com staff writers
Researchers at Thomas Jefferson University Hospital have shown that age 45 is no longer a useful predictor of negative outcomes in the staging of papillary thyroid cancer patients, according to a presentation last month at the American Thyroid Association annual meeting in Quebec City.
October 10, 2012
Study: Graphic smoking warnings work
By DrBicuspid.com staff writers
A new study suggests that graphic or emotional antismoking advertisements are effective, according to an article on Newswise.
October 9, 2012
UCLA gets $3.8M for saliva test to predict PTSD risk
By DrBicuspid.com staff writers
A team of researchers at the University of California, Los Angeles (UCLA) School of Dentistry, has been awarded a $3.8 million research grant to develop a salivary-biomarker approach for identifying individuals at risk of developing post-traumatic stress disorder (PTSD) and depression following a traumatic event.
October 8, 2012
PET imaging aids in follow-up of HNSCC patients
By DrBicuspid.com staff writers
Positron emission tomography (PET) imaging with F-18 fluorothymidine during treatment and early follow-up could predict therapeutic response and identify patients who need close follow-up to detect persistent or recurring head and neck squamous cell carcinomas (HNSCCs), according to a study published in the Journal of Nuclear Medicine.
October 4, 2012
New gene test detects early cancer risk
By DrBicuspid.com staff writers
Researchers from Queen Mary, University of London have developed a new gene test that may detect precancerous cells in patients with oral lesions that appear to be benign.
October 3, 2012
Photodynamic therapy targets oral dysplasia, oral bacteria
By Kathy Kincade
Topical photodynamic therapy (PDT) -- which combines a photosensitizing agent with a visible light source to disrupt certain cellular processes -- has a bright future in dentistry, providing more selectivity and flexibility when treating patients with oral lesions and microbial diseases of the oral cavity.
October 3, 2012
2011 12 21 16 36 48 952 Uvula Tongue Tonsils 70
Previous Page
Page 38 of 87
Next Page